Paul Kamudoni

Elevating the Patient Voice in Early Phase Oncology Drug Development: The Value of Patient‐Reported Outcomes in Dosage Optimization Leveraging Clinical Pharmacology Principles

Jatinder Kaur Mukker, Perrine Courlet, Paul Kamudoni, Karthik Venkatakrishnan

us, de, ch (code pays fourni par la source)

72731 Clinically meaningful thresholds for percent change in CLASI-A scores in adults with cutaneous manifestations of lupus: A post-hoc analysis of Phase 2 WILLOW study

Victoria Werth, Benjamin F. Chong, Anthony Raborn, Yulia Dyachkova et autres

us, de (code pays fourni par la source)

Maximising the impact of patient-reported outcome and patient preference data for drug marketing: a review of pharmaceutical websites

Olalekan Lee Aiyegbusi, Paul Kamudoni, Roger Wilson, Melanie Calvert

gb, de, us (code pays fourni par la source)

PCR58 INSIGHTS INTO RANGE OF MOTION (ROM) AND PHYSICAL FUNCTION (PF) CHANGES EXPERIENCED BY PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) IN THE MANEUVER PHASE 3 TRIAL: RESULTS FROM EXIT INTERVIEWS

Vinod Ravi, Paul Kamudoni, A Beyer, Niki Karachaliou et autres

PCR18 CHANGES IN PAIN AND STIFFNESS EXPERIENCED BY PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) IN THE MANEUVER PHASE 3 TRIAL: INSIGHTS FROM EXIT INTERVIEWS

Vinod Ravi, Paul Kamudoni, A Beyer, Niki Karachaliou et autres

us, de, gb, il, nl (code pays fourni par la source)

Optimising patient centred drug development to realise impact

Melanie Calvert, Paul Kamudoni, Christina Yap, C. J. Snyder et autres

gb, de, us (code pays fourni par la source)

Development and Validation of the Japanese Version of the Hyperhidrosis Quality of Life Index

Sayaka Ogawa, Jun Tayama, Paul Kamudoni, Sam Salek et autres

jp, de, gb (code pays fourni par la source)

The importance of patient-reported outcomes: A call for their integration in the routine care of patients with multiple sclerosis

Samantha Cruz Rivera, Stephanie Buxhoeveden, Olalekan Lee Aiyegbusi, Nina Bozinov et autres

gb, us, de (code pays fourni par la source)

A plain language summary of a study exploring the experiences of people with relapsing–remitting multiple sclerosis: what symptoms and impacts of the disease matter most and how can they be evaluated better?

Amy Barrett, Oyebimpe Olayinka-Amao, Tjalf Ziemssen, Trishna Bharadia et autres

us, de (code pays fourni par la source)

Identifying meaningful aspects of health and concepts of interest for assessment in systemic lupus erythematosus: implications for digital clinical measure development

Paul Kamudoni, Kate Lyden, Oliver Günther, Vikas Jaitely et autres

de, us, fr (code pays fourni par la source)

HSD61 One-Year Healthcare Utilization in People With Multiple Sclerosis and Controls in Wales

Helen Evans, Ian Farr, James Witts, Elaine Craig et autres

gb, de (code pays fourni par la source)

SA96 Scientific and Operational Guidelines for Conduct of Embedded Interviews With Participants in Clinical Trials

Sally Lanar, Alexia Marrel, Anne-Sophie Michel, Jeong‐Yeol Park et autres

gb, it, de (code pays fourni par la source)